ArticleP & T : a peer-reviewed journal for formulary management2012

Ipilimumab (yervoy) prolongs survival in advanced melanoma: serious side effects and a hefty price tag may limit its use.

Chris FellnerPubMed ↗Full text ↗

No numbers read from the abstract.